Работы, цитирующие эту работу

Работ: 4

Работа: Multiple myeloma: 2022 update on diagnosis, risk stratification, and management

1. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   СтатьяCAR-T cell therapy researchHeliyon2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.102962

2. Exploring Cellular Immunotherapy Platforms in Multiple Myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   ПрепринтCAR-T cell therapy researchSSRN Electronic Journal2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.preprint.000164

3. An odyssey of monoclonal gammopathies: focusing on precursors and the progression from MGUS and SMM to multiple Myeloma, with a brief overview of novel therapeutic strategies

   Xin Xin, Chunhui Fan, Ran Sheng +7

   СтатьяMultiple Myeloma Research and TreatmentsClinical and Experimental Medicine2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.000299

4. The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma

   Azat Karabekov, Vadim Kemaikin, Zhandos Burkitbayev +15

   СтатьяMultiple Myeloma Research and TreatmentsJournal of Clinical Medicine2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.015051